Trial · NCT06887998
The Effect of Oral Gabapentin on Emergence Agitation and Delirium in Adult Patients After Nasal Surgery.
NCT06887998, Phase 3, Not yet recruiting, Cairo University
3 sourcestrials-2026-11-12-0.4.0
Cite this record
ConductScience Library. The Effect of Oral Gabapentin on Emergence Agitation and Delirium in Adult Patients After Nasal Surgery. Trials, record NCT06887998. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06887998
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- The Effect of Oral Gabapentin on Emergence Agitation and Delirium in Adult Patients After Nasal Surgery.
- NCT number
- NCT06887998
- Status
- Not yet recruiting
- Phases
- Phase 3
- Enrollment
- 63 participants, estimated
- Lead sponsor
- Cairo University
- Conditions
- Emergence Agitation
- Interventions
- Gabapentin 600 mg capsules, Gabapentin 400 mg capsules, Placebo
- First posted
- 2025-03-21
- Last updated
- 2025-03-21
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Asessment of emergence agitation | through study completion, an average of 1 year | Asessment of emergence agitation by Richmond Agitation Sedation Scale(RASS) (score +1 or more) maximum value is +4 (combative) andminimum value is - (unarousable) |
| Secondary | Duration of emergence | through study completion, an average of 1 year | The time in minutes from the discontinuation of anesthesia till the time of spontaneous eye opening or to verbal command |
| Secondary | Duration of Post Anesthesia Care Unit (PACU)stay | through study completion, an average of 1 year | the time in minutes from arrival to Post Anesthesia Care Unit (PACU) to discharge to ward |
| Secondary | Number of patients had Postoperative pain | through study completion, an average of 1 year | Postoperative pain through Numerical Rating Scale (0 represents no pain and 10 represents worst possible pain) |
| Secondary | Number of patients required postoperative opioids and total dose. | through study completion, an average of 1 year | |
| Secondary | Number of patients had postoperative nausea and vomiting (PONV). | through study completion, an average of 1 year | |
| Secondary | 1. Heart rate | through study completion, an average of 1 year | heart rate in beat per minute (bpm) will be recorded every 5 minutes till the end of operation. |
| Secondary | systolic, diastolic and mean arterial blood pressure | through study completion, an average of 1 year | systolic, diastolic and mean arterial blood pressure in millimeter of mercury (mmHg) will be recorded every 5 minutes till the end of operation. |
| Secondary | Oxygen saturation | through study completion, an average of 1 year | Oxygen saturation in percentage will be recorded every 5 minutes till the end of operation. |
| Secondary | Duration of extubation | through study completion, an average of 1 year | the time in minutes from discontinuation of the anesthetic to removal of endotracheal tube |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 29925328 | BACKGROUND |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Source
- Release
- trials-2026-11-12-0.4.0
- Release manifest SHA-256
- 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4
- Registry capture
- 2026-11-12
- Results copy, AACT
- 2026-03-23
- NIH clinical studies file
- 2026-11-13
Source ClinicalTrials.gov
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNone stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06887998
GET https://conductscience.org/api/trials/v1/NCT06887998/registered